NKGen Biotech, Inc. Common Stock (NKGN)
USD 0.49
(8.26%)
USD 0.49
(8.26%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -21.94 Million | -22.55 Million | -19.54 Million |
| Net Income | -82.95 Million | -26.75 Million | -23.26 Million |
| Depreciation & Amortization | 1.2 Million | 1.65 Million | 1.24 Million |
| Deferred income taxes | -6.51 Million | 177 Thousand | 143 Thousand |
| Stock-based compensation | 4.13 Million | 69 Thousand | 93 Thousand |
| Change in working capital | 2.22 Million | 30 Thousand | 932 Thousand |
| Other non-cash items | 59.95 Million | 2.27 Million | 1.3 Million |
| Investing Cash Flow | -48 Thousand | -163 Thousand | -459 Thousand |
| Investments in PPE | -48 Thousand | -163 Thousand | -459 Thousand |
| Acquisitions | - | - | - |
| Investment purchases | - | - | -171.61 Million |
| Sales/Maturities of investments | - | 568.64 Thousand | - |
| Other Investing Activities | -48 Thousand | -568.64 Thousand | 171.61 Million |
| Financing Cash Flow | 22.15 Million | 22.48 Million | 20.15 Million |
| Debt repayment | -26.2 Million | -675 Thousand | -404 Thousand |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 11.89 Million | 161 Thousand | 63 Thousand |
| Other Financing Activities | -15.84 Million | - | - |
| Accounts receivables | 29 Thousand | -29 Thousand | 111 Thousand |
| Accounts payables | - | - | - |
| Inventory | - | - | - |
| Other working capital | 2.19 Million | 59 Thousand | 821 Thousand |
| Cash at beginning of period | 117 Thousand | 351 Thousand | 199 Thousand |
| Cash at end of period | 276 Thousand | 117 Thousand | 351 Thousand |
| Capital Expenditure | -48 Thousand | -163 Thousand | -459 Thousand |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 159 Thousand | -234 Thousand | 152 Thousand |
| Free Cash Flow | -21.99 Million | -22.72 Million | -20 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.08 Million | -5.38 Million | -33.6 Million | -82.95 Million | -33.17 Million | -1.83 Million |
| Depreciation & Amortization | 326 Thousand | 326 Thousand | 300 Thousand | 1.2 Million | 300 Thousand | - |
| Deferred income taxes | - | - | -1.52 Million | -6.51 Million | - | - |
| Stock-based compensation | 1.09 Million | 1.11 Million | 928 Thousand | 4.13 Million | - | - |
| Change in working capital | 123 Thousand | 2.27 Million | 1.41 Million | 2.22 Million | -2.45 Million | 2.41 Million |
| Other non-cash items | -662 Thousand | -601 Thousand | 25.55 Million | 59.95 Million | 21.98 Million | -1.13 Million |
| Investing Cash Flow | -15 Thousand | 35 Thousand | -18 Thousand | -48 Thousand | -113.37 Million | 113.26 Million |
| Investments in PPE | - | - | -18 Thousand | -48 Thousand | -30 Thousand | - |
| Acquisitions | - | 35 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | 330 Thousand | -330 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | 113.59 Million |
| Other Investing Activities | -15 Thousand | - | - | - | -113.67 Million | - |
| Financing Cash Flow | 6.05 Million | 4 Million | -1.8 Million | 22.15 Million | 136.83 Million | -112.87 Million |
| Debt repayment | -6.49 Million | -1.47 Million | -168 Thousand | -26.2 Million | -25.95 Million | -416.71 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | 113.29 Million | -113.29 Million |
| Common Stock Issuance | - | 250 Thousand | 1000.00 | 11.89 Million | 11.88 Million | - |
| Other Financing Activities | -1.3 Million | 2.28 Million | -1.53 Million | -15.84 Million | -14.3 Million | - |
| Accounts receivables | - | - | - | 29 Thousand | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 123 Thousand | 2.27 Million | 1.41 Million | 2.19 Million | -2.08 Million | 2.41 Million |
| Cash at beginning of period | 284 Thousand | 276 Thousand | 9.03 Million | 117 Thousand | 41.45 Thousand | 206.8 Thousand |
| Cash at end of period | 329 Thousand | 284 Thousand | 276 Thousand | 276 Thousand | 9.03 Million | 41.45 Thousand |
| Capital Expenditure | - | - | -18 Thousand | -48 Thousand | -30 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | -518.15 Thousand | - |
| Net cash flow / Change in cash | 45 Thousand | 8000.00 | -8.76 Million | 159 Thousand | 8.99 Million | -165.34 Thousand |
| Free Cash Flow | -5.99 Million | -4.03 Million | -6.95 Million | -21.99 Million | -13.97 Million | -552.05 Thousand |
SVII
PLMI
GGAZF
BONAV-B
AEDAS
NXS